Patent Trouble

Genentech has accused the University of Pennsylvania of committing "patent fraud," reports The Daily Pennsylvanian's Laura Cofsky. The company is suing the school over a cancer treatment they both say is theirs, Cofsky says. Penn tested the treatment on transgenic mice engineered to develop cancer, and accused Genentech of patent infringement when the school noticed a patent from the company for the same treatment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.